Test - Physician's Channel - Mount Sinai New York

Skip to main content

Extraordinary advances are happening at the Mount Sinai Health System, and we want you to be among the first to know. Mount Sinai Physician’s Channel will show you some of the innovative procedures, developments in patient care, and complex cases that are being handled in our world-class facilities. We invite you to come back often to stay on top of what’s new in your specific field.

Refer a Patient Online

Or call 212-241-4983

Featured Items

New Content

Mount Sinai Researchers Move Closer to a Cure for Diabetes

Mount Sinai Researchers Move Closer to a Cure for Diabetes

New research confirms a novel route for human beta cell regeneration.

Cancer Immunotherapy at Mount Sinai: Progress Towards Curing the Uncurable

Cancer Immunotherapy at Mount Sinai: Progress Towards Curing the Uncurable

Mount Sinai is moving the bar on immunotherapy to improve outcomes for patients

Mount Sinai Adds a Rehab Component to Its Management of Pulmonary Disease

Mount Sinai Adds a Rehab Component to Its Management of Pulmonary Disease

Mount Sinai Health System recently opened a comprehensive pulmonary rehabilitation program geared to patients with exercise limitations attributable to the lung or other organs. It offers them 8 to 12 weeks of muscle strengthening, helpful ...

Uncovering the Familial Link in Women with Postpartum Psychosis

Uncovering the Familial Link in Women with Postpartum Psychosis

A large cohort study from Mount Sinai provides evidence, for the first time, on familial risk of postpartum psychosis. The findings pave the way for preventive work that can be done for women at increased risk.

Exploring Links Between ‘Forever Chemicals’ and Thyroid Cancer

Exploring Links Between ‘Forever Chemicals’ and Thyroid Cancer

A group of per- and polyfluoroalkyl substances (PFAS)—endocrine-disrupting chemicals commonly dubbed "forever chemicals" due to their ability to persist in the environment—has long been thought to contribute to cancer risk. A Mount Sinai ...

As Technology Progresses, Aneurysm Treatments Become Safer and More Reasonable to Consider

As Technology Progresses, Aneurysm Treatments Become Safer and More Reasonable to Consider

Observing the 2.4 mm aneurysm in one female patient seemed reasonable in 2013. But when the evolution of endovascular techniques and technology provided an opportunity to cure her aneurysm in 2024, the 70-year-old patient sought treatment ...

A Combination Treatment, Including Harmine, Can Increase Human Insulin-Producing Cells in Vivo

A Combination Treatment, Including Harmine, Can Increase Human Insulin-Producing Cells in Vivo

Mount Sinai researchers have demonstrated that a two-drug combination to enable the regeneration of insulin-producing pancreatic beta cells for people with diabetes. One of the drugs, harmine, is a natural product found in plants.

PRECAD Trial to Explore If Controlling Risk Factors at Early Age Can Prevent Cardiovascular Events in Later Life

PRECAD Trial to Explore If Controlling Risk Factors at Early Age Can Prevent Cardiovascular Events in Later Life

The new clinical trial, led by Valentín Fuster, MD, PhD, is responding to clinical evidence that the atherosclerotic process starts early in life, and even in young adults deemed otherwise healthy can pave the way for cardiovascular events.

Specialty Reports November 2024

Specialty Reports November 2024

Valentin Fuster, MD, PhD, Wins Prestigious Award From the International Atherosclerosis Society

Valentin Fuster, MD, PhD, Wins Prestigious Award From the International Atherosclerosis Society

President of Mount Sinai Fuster Heart Hospital given top honor for his contributions to the understanding and treatment of atherosclerosis.

For the First Time, Sex Differences in Human Vascular Aging Linked to Brain Degeneration and Cognitive Impairment

For the First Time, Sex Differences in Human Vascular Aging Linked to Brain Degeneration and Cognitive Impairment

A groundbreaking study recently published in Science Translational Medicine reveals, for the first time, sex differences in human vascular aging linked to brain degeneration and cognitive impairment.

Revolutionizing Wound Care at Mount Sinai: The Role of an AI Tool in Preventing Hospital Acquired Pressure Injuries

Revolutionizing Wound Care at Mount Sinai: The Role of an AI Tool in Preventing Hospital Acquired Pressure Injuries

Discover how AI is transforming wound care and reducing hospital acquired pressure injuries - improving patient outcomes and saving costs

Study Reveals New Way to Unlock Blood-Brain Barrier, Potentially Opening Doors to Treat Brain and Nerve Diseases

Study Reveals New Way to Unlock Blood-Brain Barrier, Potentially Opening Doors to Treat Brain and Nerve Diseases

Researchers at the Icahn School of Medicine at Mount Sinai have developed an innovative approach—demonstrated in mouse models and isolated human brain tissue—to safely and effectively deliver therapeutics into the brain, providing new ...

The Friedman Brain Institute Fall 2024

The Friedman Brain Institute Fall 2024

Mount Sinai Team Shows AI Can Detect Serious Neurologic Changes in Babies in the NICU Using Video Data Alone

Mount Sinai Team Shows AI Can Detect Serious Neurologic Changes in Babies in the NICU Using Video Data Alone

Study findings could serve as a foundation for broader neuro-monitoring applications across intensive care units globally

Mount Sinai Researchers Have Uncovered the Mechanism in the Brain That Constantly Refreshes Memory

Mount Sinai Researchers Have Uncovered the Mechanism in the Brain That Constantly Refreshes Memory

Mount Sinai researchers have discovered for the first time a neural mechanism for memory integration that stretches across both time and personal experience.

Mount Sinai Researchers Enhance Screening Methods to Prevent Spread of Drug-Resistant Fungal Infections in Hospitals

Mount Sinai Researchers Enhance Screening Methods to Prevent Spread of Drug-Resistant Fungal Infections in Hospitals

Expanded protocols promote early detection in high-risk patients and prevent hospital outbreaks of Candida auris.

AI Brings a Quantum Leap in the Science of Evaluating and Treating Sleep Apnea

AI Brings a Quantum Leap in the Science of Evaluating and Treating Sleep Apnea

Sleep researchers at Mount Sinai have made a major breakthrough by developing a new model that analyzes sleep study data using generative artificial intelligence. This advance provides a robust profile of patient risk for not just cardiovascular ...